Consolidating above prior highs following a considerable gap up and volume-driven gain 11/05/15 on M&A news. Prior mid-day reports repeatedly cautioned members - "Reported earnings +20% on +12% sales revenues for the Sep '15 quarter, and prior quarterly comparisons did not show solid earnings increases above the +25% minimum earnings guideline (C criteria). Completed a new Public Offering on 12/11/13."
Consolidating above prior highs following a considerable gap up and volume-driven gain 11/05/15 on M&A news. Prior mid-day reports repeatedly cautioned members - "Reported earnings +20% on +12% sales revenues for the Sep '15 quarter, and prior quarterly comparisons did not show solid earnings increases above the +25% minimum earnings guideline (C criteria). Completed a new Public Offering on 12/11/13."
Consolidating above prior highs following a considerable gap up and volume-driven gain 11/05/15 on M&A news. Prior mid-day reports repeatedly cautioned members - "Reported earnings +20% on +12% sales revenues for the Sep '15 quarter, and prior quarterly comparisons did not show solid earnings increases above the +25% minimum earnings guideline (C criteria). Completed a new Public Offering on 12/11/13."
Consolidating above prior highs following a considerable gap up and volume-driven gain 11/05/15 on M&A news. Prior mid-day reports repeatedly cautioned members - "Reported earnings +20% on +12% sales revenues for the Sep '15 quarter, and prior quarterly comparisons did not show solid earnings increases above the +25% minimum earnings guideline (C criteria). Completed a new Public Offering on 12/11/13."
Consolidating above prior highs following a considerable gap up and volume-driven gain 11/05/15 on M&A news. Prior mid-day reports cautioned members - "Reported earnings +20% on +12% sales revenues for the Sep '15 quarter, and prior quarterly comparisons did not show solid earnings increases above the +25% minimum earnings guideline (C criteria). Completed a new Public Offering on 12/11/13."
Pulling back for a 2nd secssion following a considerable gap up and volume-driven gain 11/05/15 on M&A news. Prior mid-day report cautioned members - "Reported earnings +20% on +12% sales revenues for the Sep '15 quarter, and prior quarterly comparisons did not show solid earnings increases above the +25% minimum earnings guideline (C criteria). Completed a new Public Offering on 12/11/13."
Pulling back today following a considerable gap up and volume-driven gain for the prior session on M&A news. Reported earnings +20% on +12% sales revenues for the Sep '15 quarter, and prior quarterly comparisons did not show solid earnings increases above the +25% minimum earnings guideline (C criteria). Completed a new Public Offering on 12/11/13.
Gapped up today for a considerable volume-driven gain and new 52-week and all-time highs. Found support near its 50 DMA line during its recent consolidation. Reported earnings -43% on +26% sales revenues for the Dec '13 quarter, whereas prior quarterly comparisons showed solid earnings increases above the +25% minimum earnings guideline (C criteria). Completed a new Public Offering on 12/11/13 while perched at its all-time high.
Proposed a new Public Offering on 12/10/13 while perched at its all-time high. Retreating with today's 3rd straight loss with ever-increasing volume and it has not formed a base of sufficient length. Prior mid-day reports noted - "Patient investors may watch for a new base to possibly form and be noted in the weeks ahead. Earnings +36% on +23% sales revenues for the Sep '13 quarter marked its 5th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). There is some old overhead supply remaining up through the $45 level, but prior highs from more than a year and three quarters ago are not usually counted as a substantial source of resistance."
Hitting a new 52-week high with above average volume behind today's 3rd straight gain in a streak of 7 consecutive gains. Found support while recently consolidating above prior highs in the $34 area, however it has not formed a base of sufficient length. Patient investors may watch for a new base to possibly form and be noted in the weeks ahead. Prior mid-day reports noted - "Earnings +36% on +23% sales revenues for the Sep '13 quarter marked its 5th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). There is some old overhead supply remaining up through the $45 level, but prior highs from more than a year and three quarters ago are not usually counted as a substantial source of resistance."
Found support while recently consolidating above prior highs in the $34 area, however it has not formed a base of sufficient length. Patient investors may watch for a new base to possibly form and be noted in the weeks ahead. Last noted in the 11/20/13 mid-day report - "Earnings +36% on +23% sales revenues for the Sep '13 quarter marked its 5th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). There is some old overhead supply remaining up through the $45 level, but prior highs from more than a year and three quarters ago are not usually counted as a substantial source of resistance."
Consolidating above prior highs in the $34 area defining initial support to watch on pullbacks. Recently rallied into new high territory with 4 consecutive volume-driven gains. Earnings +36% on +23% sales revenues for the Sep '13 quarter marked its 5th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). There is some old overhead supply remaining up through the $45 level, but prior highs from more than a year and three quarters ago are not usually counted as a substantial source of resistance.
Pulling back today following a considerable gap up gain on the prior session for another new 52-week high. Prior highs define initial support to watch on pullbacks. Volume was heavy while recently rallying above previously stubborn resistance in the $34 area with 4 consecutive gains. Earnings +36% on +23% sales revenues for the Sep '13 quarter marked its 5th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). Prior mid-day reports cautioned - "It faces resistance due to overhead supply up through the $45 level."
Held its ground following a considerable gap up gain on 11/07/13, and it is hitting another new 52-week high today while rallying above previously stubborn resistance in the $34 area with 4 consecutive volume-driven gains. Earnings +36% on +23% sales revenues for the Sep '13 quarter marked its 5th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). Prior mid-day reports cautioned - "It faces resistance due to overhead supply up through the $45 level."
Held its ground following a considerable gap up gain on 11/07/13, and hitting a new 52-week high today while rallying above previously stubborn resistance in the $34 area. Earnings +36% on +23% sales revenues for the Sep '13 quarter marked its 5th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). Prior mid-day reports cautioned - "It faces resistance due to overhead supply up through the $45 level."
Holding its ground today following a considerable gap up gain on the prior session, touching a new 52-week high while challenging stubborn resistance in the $34 area. Earnings +36% on +23% sales revenues for the Sep '13 quarter marked its 5th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). Prior mid-day reports cautioned - "It faces resistance due to overhead supply up through the $45 level."